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Abstract
Background: Brain tumor etiology is poorly understood. Based on their ability to pass through the blood–brain
barrier, it has been hypothesized that exposure to metals may increase the risk of brain cancer. Results from the
few epidemiological studies on this issue are limited and inconsistent.
Methods: We investigated the relationship between glioma risk and occupational exposure to five metals - lead,
cadmium, nickel, chromium and iron- as well as to welding fumes, using data from the seven-country INTEROCC
study. A total of 1800 incident glioma cases and 5160 controls aged 30–69 years were included in the analysis.
Lifetime occupational exposure to the agents was assessed using the INTEROCC JEM, a modified version of the
Finnish job exposure matrix FINJEM.
Results: In general, cases had a slightly higher prevalence of exposure to the various metals and welding fumes
than did controls, with the prevalence among ever exposed ranging between 1.7 and 2.2% for cadmium to 10.2
and 13.6% for iron among controls and cases, respectively. However, in multivariable logistic regression analyses,
there was no association between ever exposure to any of the agents and risk of glioma with odds ratios (95%
confidence intervals) ranging from 0.8 (0.7–1.0) for lead to 1.1 (0.7–1.6) for cadmium. Results were consistent
across models considering cumulative exposure or duration, as well as in all sensitivity analyses conducted.
Conclusions: Findings from this large-scale international study provide no evidence for an association between
occupational exposure to any of the metals under scrutiny or welding fumes, and risk of glioma.
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Background
The age-standardized incidence of primary malignant
brain tumors is approximately 4.7–5.7 per 100,000
population worldwide, with rates reported to be higher
in more economically developed countries [1, 2].
Twenty-four percent of brain tumors in adults are
gliomas, with the incidence being slightly higher in men
than in women. Glioblastomas and other malignant
gliomas represent approximately 75% of malignant brain
tumors [3]. For all ages and subtypes, the 5-year survival
rate following diagnosis is between 20 and 30% in the
U.S. [1]. Survival can vary greatly based on subtype,
ranging from 3.3% for glioblastoma multiforme to over
70% for lower-grade gliomas. Aside from histologic
subtype, the best predictor of survival is age at diagnosis,
with older patients facing poorer outcomes.
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The etiology of brain tumors is not well understood.
Studies on possible risk factors for brain tumors have re-
cently been reviewed [4]. Most studies show an increased
risk of brain tumor after exposure to ionizing radiation.
Based on positive associations between glioma and expos-
ure to radiofrequency electromagnetic fields (RF-EMF)
from wireless phones, RF-EMF have been classified as
possibly carcinogenic [5]. Other risk factors that have been
investigated include allergies and asthma, certain viruses,
previous head injury, genetic factors, diet and smoking. As
well, demographic factors such as race, sex and socio-eco-
nomic status have been explored. To date, however, find-
ings have been largely inconsistent [1–4, 6].
Workers in a number of occupations entailing expos-
ure to neurotoxic and carcinogenic compounds have
also been studied. Occupational exposure to metals has
been of particular interest with respect to brain tumors
owing to the ability of several metals to pass through the
blood–brain barrier and to be up-taken via olfactory
pathways into the brainx [7–9]. An increased risk of
glioma has been reported in men with occupational ex-
posures to arsenic, mercury and petroleum products
[10]. Lead exposure has been linked to brain cancer
mortality [11, 12] and glioma incidence [11–13]. In a co-
hort of Finnish women, elevated risks of brain-nervous
system cancer were observed with occupational expos-
ure to iron, chromium, lead and cadmium, albeit none
of the risk estimates achieved statistical significance [14].
Brain cancer mortality was found to be elevated among
chromium-exposed workers in Japan [15] and welders
using chromium-nickel steel [16]. Glioma risk was
associated with metal exposure as a group [17]. Other
occupational studies document no association between
glioma and exposure to metal [18] or lead [19, 20], or
between brain cancer and lead [21]. Many of these
studies were hampered by small numbers of brain can-
cer cases, crude occupational histories, or weak exposure
information. A recent study reported an increased risk
of brain cancer with environmental exposure to lead
emissions from petrol [22].
Evaluating associations between occupational expo-
sures and glioma is challenging. Occupational exposures
are complex, and can include many different substances
at varying concentrations. Therefore, detailed occupa-
tional histories and retrospective exposure estimates are
required. Due to low incidence, large populations are
needed to obtain a sufficient number of glioma cases for
study. In earlier studies, this has led some researchers to
group all brain tumors together instead of studying
specific subtypes which may be linked to different risk
factors. Given these issues, associations between glioma
and occupational exposures are likely best studied in the
context of a large case–control study with detailed occu-
pational histories and exposure estimates.
In the late 1990’s, an international case–control study
of mobile phone exposure and brain tumors was
launched [23]. The INTERPHONE study included data
from 13 countries. In addition to a detailed history of
mobile phone use, data were collected on a number of
other known and possible risk factors, along with de-
tailed occupational histories. Seven of the 13 participat-
ing countries, comprising 10 study centers, constituted
the INTEROCC study group established to evaluate the
role of occupational exposures in brain tumors. Analyses
focusing on exposure to solvents, combustion products,
dusts and other chemical agents, and extremely low
frequency magnetic fields (ELF) have been conducted
[24–28]. Risks were close to null for all agents and
glioma, other than for ELF which were associated with
increased risk. Moreover, an analysis of occupational
metal exposure and meningioma risk in INTEROCC
[29], including data on 1906 adult meningioma cases
and 5565 population controls, suggested positive associ-
ations for ever vs. never exposure for several metals with
the strongest association observed for iron exposure
(OR = 1.26, 95% CI 1.0–1.58) particularly among women
(OR = 1.70, 95% CI 1.0–2.89). Positive trends emerged
for both cumulative exposure and duration. Associations
persisted after consideration of other occupational metal
co-exposures. In this article, we report on associations
between glioma and occupational exposure to five
metals- lead, cadmium, nickel, chromium and iron- as
well as to welding fumes, using the INTEROCC data.
Methods
Study population
The INTEROCC study is a multicenter population-based
case–control study including 10 centers from 7 countries
(Australia, Canada, France, Germany, Israel, New Zealand
and the United Kingdom [UK]) participating in the INTER-
PHONE study [23]. For most countries, eligible cases were
all patients between 30 and 59 years of age and diagnosed
with a primary glioma or meningioma tumor between 2000
and 2004. In Germany and the UK, the upper age limit was
69 years while Israel had no upper age limit for recruit-
ment. Only subjects aged 30 to 69 years were included in
the present analyses. The procedures for ascertainment of
cases and detailed study methods have been described
previously [23]. The present analysis is confined to glioma
cases. Population controls were randomly selected from
electoral lists (Australia, Canada-Montreal, France, New
Zealand), population-based registries (Canada-Vancouver,
Germany, Israel), patient lists (UK), or random digit dialing
(Canada-Ottawa). They were frequency or individually
matched to cases by sex, age (within 5 years) and center. In
total, 2054 glioma cases and 5601 controls were recruited
in the 7 countries. Participation rates were 68% for glioma
cases and 50% for controls.
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Data collection
Trained interviewers conducted face-to-face interviews
with study participants using a computer-assisted
questionnaire. When the study subject had died or was
too ill to be interviewed, the interview was conducted
with a proxy respondent. Detailed information was
collected on socio-economic and lifestyle characteristics
(including lifetime use of mobile phones, smoking
habits, and occupational history), and medical history
[23]. An occupational calendar was used to collect life-
time work histories, covering all jobs held by partici-
pants for more than 6 months. It elicited information on
the job title, description of tasks, and the start and end
year for each job, and, in some countries, company
name and description of activities of the company. Each
job held by subjects was coded according to inter-
national occupation and industry classifications: the
International Standard Classification of Occupations
editions 1968 (ISCO68 [30]) and 1988 (ISCO88 [31]),
and the International Standard Industrial Classification
of All Economic Activities, revision 2 (ISIC71) [32].
Common coding guidelines were provided to each cen-
ter in order to foster homogeneous coding practices. An
inter-rater trial was conducted at the start of coding and
results were discussed with each center in a further
effort to ensure consistency of coding [33].
Occupational exposure assessment
Occupational exposure to the agents was assessed using
a modified version of the Finnish job exposure matrix
FINJEM [34]. The Finnish occupation classification
system contains 311 major occupational groups and
covers the calendar period 1945 to 2003, divided into
several sub-periods. FINJEM can translate an occupa-
tional history into a history of exposure to about 90
chemical, physical, behavioral, microbiological,
ergonomic and psychosocial factors, including the 6
exposures under investigation in this paper. FINJEM
provides two exposure estimates for each specific com-
bination of occupation, calendar sub-period, and agent:
the proportion of workers in that occupation who were
considered to be exposed to the agent (P) and the mean
level of exposure among the exposed (L) expressed in
units of concentration. When P was considered to be
less than 5%, the level in FINJEM was set to zero. The
estimates of P and L were based on exposure measure-
ments, hazard surveys, and the judgements by Finnish
occupational hygienists.
Since FINJEM uses the Finnish occupational coding
system and the INTEROCC work histories were coded
according to international classifications, it was neces-
sary to develop a “crosswalk” between the Finnish codes
and the ISCO68. FINJEM was further modified for our
purposes with, for example, the time window 1960–1984
split into pre and post-1974 periods. Also, specific FIN-
JEM entries were modified for some of the exposures of
interest to increase consistency and specificity of exposure
assessment. For instance, FINJEM was modified by using
expert-based exposure estimates developed for a
population-based case–control study of lung cancer in
Montréal. Assignments of exposure were peer reviewed
by an international panel of occupational hygienists to en-
sure that the revised JEM estimates better reflected the
prevailing exposure patterns in the seven participating
countries. This modified instrument, referred to as the
INTEROCC JEM, is described in Van Tongeren et al. [35].
Statistical analyses
From the 2054 glioma cases and 5601 controls recruited,
1856 cases and 5189 controls met the 30–69 years age
restriction. A small number of participants (56 cases, 29
controls) were excluded as they had a personal or family
history of neurofibromatosis or tuberous sclerosis, or
had missing or erroneous occupational history informa-
tion, yielding 1800 glioma cases and 5160 controls for
analysis.
For each exposure, three indices were defined for the
main analysis: i) ever vs. never exposed; ii) lifetime cu-
mulative exposure; and iii) duration of exposure. As
noted above, for each job, the INTEROCC JEM provides
the probability (P) that a worker in that occupation was
exposed to that agent. There are several approaches for
deriving an “ever exposure” variable from the INTER-
OCC JEM. If we designate as exposed to a given agent
all those who worked in an occupation with even a small
probability of exposure according to the JEM, say as low
as 5%, it would be very sensitive, but most of the sub-
jects labelled as exposed would have had a low probabil-
ity of exposure. At the other extreme, if we use a high
value of P as the threshold, say 95%, then it would be
very specific, but a large fraction of workers truly ex-
posed would be labelled as unexposed. The trade-off be-
tween sensitivity and specificity also has implications for
the estimated prevalence of exposure. In order to give
greater weight to sensitivity than specificity, but not to
exaggerate this choice unduly, we used as the a priori
threshold P ≥ 25%. Thus, ever exposure to a given agent
was defined as having held at least one job with a prob-
ability of exposure of at least 25% and for at least 1 year.
Subjects who had held jobs with a probability of expos-
ure of less than 25% but greater than 5%, or for less than
1 year were considered to be of “uncertain” exposure
status and were assigned to a separate category (not
reported). The lifetime cumulative exposure index was
defined among ever exposed (corresponding to the ever
definition criteria) as the sum of the product of the
probability of exposure (P), the level of exposure (L),
and the duration for each job held by a subject. The
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continuous cumulative exposure index was categorized
according to tertiles of the distribution among exposed
controls. We also calculated the total duration of expos-
ure, defined as the sum of the duration of exposure for
each job held by a subject (corresponding to the ever
definition criteria) minus the possible overlap period
between two jobs. To allow sufficient time between oc-
cupational exposure and disease onset, all exposures that
had occurred within 5 years of the reference date (age at
diagnosis for cases and age at interview for controls)
were not taken into account, therefore establishing a lag
period of 5 years.
For all analyses, the reference category included sub-
jects who had never been exposed to the specific chem-
ical agent of interest. Because of the exploratory nature
of these analyses, each exposure was considered
independently.
Associations between glioma and each of the 6 expo-
sures (5 metals plus welding fumes) were estimated
using conditional logistic regression stratified by sex, age
(5-year categories) and center. Further, all analyses were
adjusted a priori for the following variables: i) age as a
continuous variable (to remove any residual confounding
due to age in the strata definition), ii) the maximum
education level attained by the subject or her/his spouse
(primary, intermediate college, tertiary), iii) the Standard
International Occupational Prestige Scale (SIOPS),
expressed as a time-weighted average across all jobs [36]
iv) antecedents of atopy, defined as ever medical diagno-
sis of allergy, asthma and/or eczema (recognized as
associated with glioma and exposure to metals [37]) and
v) the respondent status (subject him/herself vs. proxy
respondent).
Missing values for the maximum level of education
attained in the household were imputed to the middle
category “intermediate college” (14 subjects). Missing
values for the SIOPS variable, occurring when the
occupation was unknown, were imputed to the median
value in the corresponding subject strata of age (5-year
categories), sex, center and maximum level of education
attained in the household (104 subjects). When variables
constituting the “antecedents of atopy” variable were
missing (22 subjects), the latter was imputed as “none”.
Sensitivity analyses
Sensitivity analyses were conducted to examine the
influence of results using different thresholds for prob-
ability of exposure, duration of exposure, and lag period
including using alternate probabilities of exposure of
P ≥ 5% and 50%, duration of exposure of 5 years, and
lag periods of 1 and 10 years. A separate set of analyses
was conducted defining the reference category as never
exposed to any metal nor to welding fumes. Further ana-
lyses were conducted restricted to: i) male participants;
ii) female participants; iii) high-grade glioma cases; iv)
glioblastoma cases; and v) participants who completed
the study interview without a proxy respondent. Ana-
lyses adjusting for cigarette smoking status at diagnosis/
interview (current, ex-smokers, never smokers) and
marital status (married vs. others) were also conducted.
Sensitivity analyses excluding one by one each of the a
priori confounders from the main results model were
also performed.
Ethics approval was obtained from all appropriate na-
tional and regional research ethics boards, including the
Ethical Review Board of IARC (Lyon) for INTERPHONE
and the Municipal Institute for Medical Investigation
(IMIM) Barcelona for INTEROCC. All participants pro-
vided written informed consent.
Results
The majority of cases (62.0%) were males whereas con-
trols were more often females (55.3%) (Table 1). The
mean (standard deviation) age of participants ranged
from 50.6 (10.0) to 51.2 (9.7) years among cases and
controls, respectively. Participants generally had a
primary or secondary level of education, were married,
and about half were never smokers. The UK and
Germany contributed the majority of participants. Proxy
respondents were used for 14.3% of glioma cases and
0.4% of controls.
There were high percentages of overlap between expos-
ure to each of the metals and welding fumes (Table 2). In
general, cases had a higher prevalence of (ever) exposure
to the various metals and welding fumes than controls
(Table 3). Exposure prevalence ranged from 1.7–2.2% for
cadmium up to 10.2–13.6% for iron among controls and
cases, respectively.
Associations between exposure to each of the 5 metals
and welding fumes, and glioma risk are also presented in
Table 3. Once covariates were included in the models,
there was no association between ever exposure to any
of the agents and glioma risk, with ORs ranging from
0.8 (95% CI 0.7–1.0) for lead to 1.1 (95% CI 0.7–1.6) for
cadmium. There was also no evidence for a trend ac-
cording to categories of cumulative exposure, including
in the highest tertile, where ORs were generally near 1.0.
Analyses based on three categories of duration of expos-
ure (1–4, 5–9, ≥10 years) yielded similar findings. The
only elevated, but non-significant ORs were observed for
cadmium, in the second tertile of cumulative exposure
(OR = 1.6, 95% CI 0.9–2.8) and among subjects exposed
5–9 years (OR = 1.4, 95%CI 0.6–3.3). Some ORs in low
exposure categories were non-significantly decreased, as
for lead and iron.
Results were similar for all of the agents upon restric-
tion of the analysis to males or to females (results not
shown), high-grade glioma cases, glioblastoma cases, or
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to self-respondents (Table 3). There was also no evi-
dence for an association according to alternate defini-
tions of P, duration or lag time for any of the agents
(Additional file 1: Table S1). This held true when using
an unexposed category that excluded exposure to any of
the metals under study. Excluding one by one each of
the a priori confounders from the main model had a
marginal impact on findings. There was no effect modi-
fication by education or smoking history (not shown).
Upon further investigation of cadmium according to
different durations and probabilities of exposure, and lag
times (Additional file 1: Table S1), a significant increase
in risk was observed in the first tertile of exposure for a
lag of 5 years, a duration ≥5 years and a probability ≥5%.
Some ORs were greater than one following the various
exposure scenarios but no clear pattern emerged and
numbers were small.
Discussion
We investigated the relationship between glioma and oc-
cupational exposure to five metals- lead, cadmium,
nickel, chromium and iron- as well as to welding fumes,
in the seven-country INTEROCC study. Overall, there
was no evidence of an association between ever expos-
ure to any of the metals or welding fumes and glioma,
with ORs generally near 1.0. No associations were
observed according to categories of cumulative exposure
or duration of exposure or to a range of alternate
assumptions regarding exposure modeling or lag time.
Results were consistent across an array of sensitivity
analyses.
In the IARC Monograph program on the evaluation of
carcinogenic risks to humans, cadmium and cadmium
compounds, chromium-6 compounds, nickel com-
pounds, welding fumes, and occupational exposure
during iron and steel founding have been classified as
human carcinogens (Group 1) while inorganic lead is
currently classified as a probably carcinogenic (Group
2A) [38–41]. However, for none of these has the brain
been identified as a target site.
Previous results from epidemiological studies examin-
ing associations between occupational metal exposure
and brain tumors are mixed. An elevated OR was ob-
served among men, but not women, with occupational
activities involving metals in a 6-country study of glioma
risk (OR = 1.24, 95% CI 0.96–1.62) (n = 1178 cases,
1987 controls), but no association emerged when self-
reports of exposure to metal or metal compounds were
used [17]. An analysis based on data from the German
INTERPHONE study group, which are subsumed in the
present analysis, suggested no association between hav-
ing ever worked in an occupational sector involving
metal production and glioma risk or according to
duration of work in the sector [18]. One U.S. study in-
cluding 489 glioma cases and 799 controls reported no
overall association between occupational lead exposure
as assessed using a quantitative lead exposure database
and detailed job-level information [19], although there
was some evidence of modification of the association
with glioblastoma multiforme by single nucleotide poly-
morphisms in genes related with oxidative stress [20]. A
positive association was observed between occupational
lead exposure and brain cancer mortality in the National
Table 1 Selected characteristics of glioma cases and controls,
INTEROCC study, 2000–2004*
Variable Glioma cases Controls
(n = 1800) (n = 5160)
Age, mean (SD) 50.6 (10.0) 51.2 (9.7)
Males, n (%) 1116 (62.0) 2308 (44.7)
Education, n (%)
Primary/secondary 766 (42.6) 2253 (43.7)
Intermediate college/professional 391 (21.7) 1085 (21.0)
Tertiary 643 (35.7) 1822 (35.3)
Proxy respondent, n (%) 257 (14.3) 23 (0.4)
Country, n (%)
Australia 277 (15.4) 665 (12.9)
Canada 169 (9.4) 649 (12.6)
France 93 (5.2) 471 (9.1)
Germany 366 (20.3) 1494 (29.0)
Israel 282 (15.7) 698 (13.5)
New Zealand 75 (4.2) 160 (3.1)
United Kingdom 538 (29.9) 1023 (19.8)
Tumor histology, n (%)
Glioblastomas 848 (47.1) -
Other 952 (52.9) -
Occupational Prestige Scale
(SIOPS), mean (SD)
43.2 (11.5) 44.0 (11.8)
Marital status, n (%)
Single 159 (8.9) 431 (8.4)
Married 1422 (79.3) 4035 (78.3)
Divorced 142 (7.9) 494 (9.6)
Widowed 62 (3.5) 190 (3.7)
Don’t know 8 (0.4) 5 (0.1)
Missing 7 (−) 5 (−)
Smoking status
Never 906 (50.3) 2521 (48.9)
Ex-smoker 386 (21.4) 1212 (23.5)
Current 508 (28.2) 1427 (27.7)
Asthma, hay fever, eczema,
n (%)
416 (23.1) 1380 (26.7)
*Cases were statistically different from controls at p < 0.05 in terms of the
following variables: age, sex, proxy respondent, country, occupational prestige,
marital status, and asthma, hay fever and/or eczema
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Longitudinal Mortality Study (OR for any expos-
ure = 1.56, 95% CI 1.00–2.43, based on 119 brain cancer
deaths) [11]. In a study linking JEM-based exposure to
individual metals and the Swedish national cancer
register [10], no clear association emerged between oc-
cupational chromium/nickel, lead, or metallic compound
exposure and glioma risk among 2.8 million men
employed in 1970 (n = 3363 glioma cases). In contrast,
in another study [14], some elevated standardized inci-
dence ratios (SIRs) for brain cancer cancer (n = 693)
were observed in a cohort of 413,000 Finnish women
with blue collar occupations in 1970 entailing exposure
to iron (SIR = 2.15, 95% CI 0.96–4.80), chromium com-
pounds (SIR = 1.51, 95% CI 0.85–2.67), lead (SIR = 1.27,
95% CI 0.81–2.01), and cadmium (SIR = 1.24, 95% CI
0.72–2.22). There was an elevated risk of brain cancer
mortality (standardized mortality ratio = 9.14, 95% CI
1.81–22.09) in a cohort of 1193 male chromium platers
in Japan, although this results was based on only three
brain cancer deaths [15]. No association was found with
brain cancer mortality in a cohort of 9122 workers with
measured blood lead levels in Great Britain, based on
23 brain cancer deaths [42]. There was a positive,
though imprecise association between ever occupa-
tional exposure to lead dust and fumes, assigned
based on a combination of expert intensity ratings
and inspection measurements, in a Shanghai general
population cohort (RR = 1.8, 95% CI 0.7–4.8, n = 77
incident brain cancer cases).
The cytotoxicity of cadmium has been demonstrated
[43]. It can alter the brain function and has been linked
to cancer development in experimental animals. Studies
on humans are suggestive of associations with cancer
sites such as the prostate and the kidney [44], but little
evidence has accrued with respect to brain cancer. In
our study, cadmium was the only agent showing some
risk estimates departing from the null value. However,
no clear patterns of risk emerged and this may result
from low numbers and statistical instability.
Most studies reporting on welding found no associ-
ation with brain cancer [45–48]. A suggestive association
emerged in a Canadian study of 1009 incident cases of
brain cancer and 5039 controls for welding over 20 years
or more [49].
Strengths of the current study include the large sample
size with 1800 glioma cases and 5160 controls, detailed
data on participant lifetime occupational history, object-
ively assigned exposure estimates, information on poten-
tial confounders, as well as information on tumor
histology and grade. Nevertheless, we found no evidence
of an association between metals or welding fumes, and
glioma risk. The null associations observed may reflect
various features of the study, including low prevalence
and misclassification of exposure. However, associations
have been previously been observed in INTEROCC,
including between occupational exposure to metal,
particularly iron, as well as to oil mist, and risk of men-
ingioma [27, 29]. In contrast with the latter positive
findings for meningioma, there were no associations
observed for glioma risk here or in other analyses asses-
sing occupational exposure to solvents, combustion
products, dusts and other chemical agents overall or
according to sex, tumor histology, tumor grade, re-
spondent status, and considering various exposure mod-
eling approaches or lag time [24, 25].
JEMs entail assigning the same set of exposures to all
subjects holding a given occupational title. They thus
overlook idiosyncratic jobs circumstances that can influ-
ence exposure levels. This typically leads to non-
differential misclassification of exposure, diminishing the
opportunity to detect a true association [50]. In a case–
control study of occupational exposure to lead there was
moderate agreement in exposure estimates between an
expert assessment of detailed work history versus a JEM
approach, with the JEM demonstrating higher specificity
(~0.9) than sensitivity (~0.5) [51]. Several steps were
undertaken in the study to adapt FINJEM for application
to the INTEROCC study, including peer review by an
Table 2 Degree of bivariate overlap in exposure to the various metals and welding fumes in INTEROCC, in glioma cases and controls
combined, 2000-2004a
Cadmium Chromium Iron Lead Nickel Welding fumes
n 130 537 772 546 659 570
Cadmium - 7.1 6.6 10.4 7.4 2.6
Chromium 29.2 - 69.6 40.3 79.8 66.0
Iron 39.2 100 - 64.1 95.6 100
Lead 43.8 41.0 45.3 - 44.5 53.0
Nickel 37.7 98.0 81.6 53.7 - 82.8
Welding fumes 11.5 70.0 73.8 55.3 71.6 -
aValues of cells in each column represent the proportion of participants with exposure to the agent in the column heading who were also exposed to the agent
in the corresponding row. For welding fumes, exposures to other metals could come from welding activities, from other activities in the same job and/or from
activities in other jobs
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Table 3 Adjusteda odds ratios (OR) and 95% confidence intervals
(CI) for the risk of glioma and exposure to each of the 5 metals
and welding fumes for a duration ≥1 year, a lag of 5 years and
P ≥ 25%
Exposure Glioma cases Controls OR (95% CI)
n (%) n (%)
Cadmium
Non-exposed 1741 (96.7) 5039 (97.7) 1.0 (Ref)
Cumulative exposure 40 (2.2) 90 (1.7) 1.1 (0.7–1.6)
≤ 111.4 μg/m3 12 (0.7) 30 (0.6) 1.0 (0.5–1.9)
> 111.4 to ≤343.8 μg/m3 19 (1.1) 31 (0.6) 1.6 (0.9–2.8)
> 343.8 μg/m3 9 (0.5) 29 (0.6) 0.7 (0.3–1.5)
Duration of exposure
1–4 years 20 (1.1) 44 (0.9) 1.1 (0.6–1.8)
5–9 years 10 (0.6) 19 (0.4) 1.4 (0.6–3.3)
≥ 10 years 10 (0.6) 27 (0.5) 0.8 (0.4–1.8)
Restricted to males 31 (2.8) 56 (2.4) 1.1 (0.7–1.8)
High grade cases 25 (2.0) 90 (1.7) 0.9 (0.6–1.5)
Glioblastomas 18 (2.1) 90 (1.7) 0.9 (0.5–1.5)
Self-respondents 38 (2.5) 89 (1.7) 1.1 (0.7–1.7)
Chromium
Non-exposed 1508 (83.8) 4535 (87.9) 1.0 (Ref)
Cumulative exposure 178 (9.9) 359 (7.0) 0.9 (0.7–1.1)
≤ 445.5 μg/m3 61 (3.4) 121 (2.3) 0.9 (0.6–1.3)
> 445.5 to ≤3000 μg/m3 57 (3.2) 119 (2.3) 0.9 (0.6–1.3)
> 3000 μg/m3 60 (3.3) 119 (2.3) 0.9 (0.6–1.3)
Duration of exposure
1–4 years 41 (2.3) 95 (1.8) 0.9 (0.6–1.3)
5–9 years 36 (2.0) 81 (1.6) 0.8 (0.5–1.2)
≥ 10 years 101 (5.6) 183 (3.5) 1.0 (0.8–1.4)
Restricted to males 175 (15.7) 337 (14.6) 0.9 (0.7–1.2)
High grade cases 124 (9.9) 359 (7.0) 0.9 (0.7–1.2)
Glioblastomas 83 (9.8) 359 (7.0) 0.8 (0.6–1.1)
Self-respondents 150 (9.7) 358 (7.0) 0.9 (0.7–1.1)
Iron
Non-exposed 1546 (85.9) 4604 (89.2) 1.0 (Ref)
Cumulative exposure 244 (13.6) 528 (10.2) 0.9 (0.7–1.1)
≤ 70 mg/m3 64 (3.6) 181 (3.5) 0.7 (0.5–1.0)
> 70 to ≤254.3 mg/m3 81 (4.5) 171 (3.3) 0.9 (0.7–1.2)
> 254.3 mg/m3 99 (5.5) 176 (3.4) 1.1 (0.8–1.5)
Duration of exposure
1–4 years 52 (2.9) 139 (2.7) 0.8 (0.6–1.2)
5–9 years 57 (3.2) 116 (2.2) 0.9 (0.6–1.3)
≥ 10 years 135 (7.5) 273 (5.3) 0.9 (0.7–1.2)
Restricted to males 237 (21.2) 493 (21.4) 0.9 (0.7–1.1)
High grade cases 181 (14.5) 528 (10.2) 1.0 (0.8–1.2)
Glioblastomas 125 (14.7) 528 (10.2) 1.2 (0.4–3.2)
Self-respondents 211 (13.7) 527 (10.3) 0.9 (0.7–1.1)
Table 3 Adjusteda odds ratios (OR) and 95% confidence intervals
(CI) for the risk of glioma and exposure to each of the 5 metals
and welding fumes for a duration ≥1 year, a lag of 5 years and
P ≥ 25% (Continued)
Lead
Non-exposed 1419 (78.8) 4296 (83.3) 1.0 (Ref)
Cumulative exposure 159 (8.8) 387 (7.5) 0.8 (0.7–1.0)
≤ 128.8 μmol/l (in blood) 45 (2.5) 128 (2.5) 0.8 (0.6–1.2)
> 128.8 to ≤413.2 μmol/l
(in blood)
47 (2.6) 131 (2.5) 0.7 (0.5–1.0)
> 413.2 μmol/l (in blood) 67 (3.7) 128 (2.5) 1.0 (0.7–1.3)
Duration of exposure
1–4 years 58 (3.2) 140 (2.7) 1.0 (0.7–1.4)
5–9 years 32 (1.8) 81 (1.6) 0.7 (0.4–1.1)
≥ 10 years 69 (3.8) 166 (3.2) 0.8 (0.6–1.1)
Restricted to males 151 (13.5) 321 (13.9) 0.9 (0.7–1.1)
High grade cases 121 (9.7) 387 (7.5) 0.9 (0.7–1.2)
Glioblastomas 85 (10.0) 387 (7.5) 0.9 (0.7–1.2)
Self-respondents 135 (8.7) 387 (7.5) 0.8 (0.7–1.0)
Nickel
Non-exposed 1534 (85.2) 4585 (88.9) 1.0 (Ref)
Cumulative exposure 215 (11.9) 444 (8.6) 0.9 (0.8–1.1)
≤ 317.2 μg/m3 55 (3.1) 149 (2.9) 0.8 (0.5–1.1)
> 317.2 to ≤951.3 μg/m3 72 (4.0) 148 (2.9) 0.9 (0.7–1.3)
> 951.3 μg/m3 88 (4.9) 147 (2.8) 1.1 (0.8–1.5)
Duration of exposure
1–4 years 46 (2.6) 128 (2.5) 0.8 (0.5–1.1)
5–9 years 51 (2.8) 104 (2.0) 0.9 (0.6–1.3)
≥ 10 years 118 (6.6) 212 (4.1) 1.0 (0.8–1.3)
Restricted to males 209 (18.7) 410 (17.8) 0.9 (0.8–1.2)
High grade cases 155 (12.4) 444 (8.6) 1.0 (0.8–1.2)
Glioblastomas 107 (12.6) 444 (8.6) 0.9 (0.7–1.2)
Self-respondents 184 (11.9) 443 (8.6) 0.9 (0.8–1.1)
Welding fumes
Non-exposed 1546 (85.9) 4606 (89.3) 1.0 (Ref)
Cumulative exposure 182 (10.1) 388 (7.5) 0.9 (0.7–1.1)
≤ 180 mg/m3 63 (3.5) 136 (2.6) 0.9 (0.6–1.2)
> 180 to ≤684 mg/m3 54 (3.0) 123 (2.4) 0.8 (0.6–1.2)
> 684 mg/m3 65 (3.6) 129 (2.5) 1.0 (0.7–1.4)
Duration of exposure
1–4 years 44 (2.4) 110 (2.1) 0.8 (0.6–1.2)
5–9 years 39 (2.2) 77 (1.5) 0.9 (0.6–1.4)
≥ 10 years 99 (5.5) 201 (3.9) 0.9 (0.7–1.2)
Restricted to males 178 (15.9) 375 (16.2) 0.9 (0.7–1.1)
High grade cases 131 (10.5) 388 (7.5) 0.9 (0.7–1.2)
Glioblastomas 95 (11.2) 388 (7.5) 0.9 (0.7–1.2)
Self-respondents 157 (10.2) 388 (7.6) 0.9 (0.7–1.1)
aAdjusted for age, educational level, occupational prestige, atopy, and
respondent status
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international panel of occupational hygienists to ensure
that INTEROCC JEM estimates better reflected the
prevailing exposure patterns in the seven participating
countries [35]. A comprehensive comparison of FINJEM
exposure estimates to those potentially encountered in
other countries could not be carried out. However, assess-
ments were found to be reasonably comparable to those
in a large population-based case–control study in
Montreal, especially for metals and welding fumes [52].
Recall bias is always a concern in interview-based
studies, but as in this case exposure relied on reporting
of the occupational history, similar degrees of accuracy
are assumed between cases and controls. There was a
relatively high proportion of proxy interviews in the case
group, but findings were similar in analyses including
and excluding proxy respondents.
As a whole, our study covers ages at diagnosis from 30
to 69 years, with some countries limited to age 59. Based
on the SEER registry, the median age at diagnosis of
glioma (all subtypes combined) is 59 years. For all sub-
types other than glioblastoma and gliosarcoma, the me-
dian age is below that [53]. It is possible that the low
numbers for older age groups in our study limited our
ability to detect associations for exposures longer than
covered here and for subtypes than tend to develop at
more advanced ages.
Conclusions
Findings from this large population-based study using a
detailed exposure assessment provide no evidence of an
association between lifetime occupational exposure to
any of the five metals under study, or to welding fumes,
and risk of developing glioma.
Additional file
Additional file 1: Table S1. Adjusteda odds ratios (OR) and 95%
confidence intervals (CI) for the risk of glioma and exposure to each of
the 5 metals and welding fumes, according to different durations and
probabilities of exposure, and lag times. (DOCX 27 kb)
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